SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " fda " 2,419 found 🔀 AI-powered Shuffle
What releasing Otis Reese means for the Patriots
The veteran linebacker was let go by the Patriots on Friday.
FDA clears autoinjector drug for home treatment of heart failure edema
A new drug delivery system may help reduce heart failure hospitalizations and related healthcare costs, which are expected to reach $70 billion by 2030.
Business impact fund available for those affected by Omaha Streetcar construction
An impact fund for businesses affected by the Omaha Streetcar construction is now taking applications.
Innovation Politics at the FDA - Petrie-Flom Center
The relationship between innovation and the Food and Drug Administration (FDA) has become a central topic of concern for a whole host of parties: academics, members of the National Academies of Sciences, Engineering, and Medicine, and several former FDA commissioners.
Amazon's surging cloud business is growing at a breakneck pace: Chart
Amazon's cloud business has entered a new orbit.
Does public health *need* MAHA?
Last week, our friend Dr. Craig Spencer sparked an ongoing volatile discussion with his Atlantic article “Public Health Needs MAHA.” Some have come out in strong dissent, others are cheering, and others are simply lamenting that we find ourselves in such a divided world to begin with. We will dare to dip our toes in these controversial waters, too. Does public health need MAHA? We think in some ways yes, and in other ways, no. MAHA leaders versus the everyday MAHA supporter The vitriol in this debate mostly comes from one collapsed distinction: the leadership of MAHA is not necessarily the same as the people who support it. Say “MAHA” and most people picture RFK Jr. Fair enough, as he coined the term and holds most of the power. And, yes, some MAHA followers treat Kennedy as something close to a saint. But talk to the grassroots, and it’s not a monolith. They’re Republicans, Democrats, and Independents. People who distrust vaccines and vaccine supporters. It’s a wide, eclectic coalition. The data backs this too: 4 in 10 Americans support the movement—that’s a lot of people! But according to polls, vaccines and medical choice (the issues most tied to Kennedy personally) are cited by only 4% as their reason for supporting the movement. For many, the motivations are much broader. Many MAHA supporters are signing up for the idea that “something needs to change” with health in this country. They’re asking good-faith questions about corporate influence on our health systems, health care costs, nutrition, chemicals, and clean air and water. These are all questions that plenty of public health professionals recognize as legitimate and also care about very deeply. Blurring the lines between the leadership and grassroots does real damage in two important ways: It hands the 4 in 10 exactly the narrative already fed—that the health ecosystem doesn’t listen, doesn’t care, and paints every critic with the same brush. It gives the actual bad actor more power. RFK Jr. has done irreparable damage and can’t be trusted. What the MAHA movement gets right A healthy population is something the public health field was literally built on, and many of these topics are things we have dedicated our lives to. Yet the MAHA movement has captivated nearly half the country in a way the public health establishment has failed to achieve. So that means MAHA is doing something right. Some of it may be timing (after a Covid-19 pandemic and deep frustration and mistrust with institutions). The movement also does three other things really well: 1. It gives a new, louder voice to system failures. While MAHA is not a monolith, one theme stays consistent across their stories: the system failed them. For some, it was the system that flooded their communities with opioids and then walked away. For others, it was the system that let their business collapse during Covid with no safety net in sight. For others still, it was the system that failed to help them manage a complex chronic illness, bouncing them from physician to physician without any real answers. And in many ways, our health ecosystems are failing Americans. Why are medical bills so incomprehensible? Why do some kids get a healthy school lunch and others don’t? Why do an epidemiologist and a MD/PhD student have to start newsletters in the middle of the biggest public health emergency in a century, just so people can get straight information? Because the systems failed. This deep-seated frustration driving many Americans to search for solutions elsewhere needs to be recognized. 2. MAHA has brilliant comms central to their efforts. MAHA figured out something most health institutions still have not: the information landscape changed. It’s participatory now, not top-down; influence runs through many nodes in a community, not one institution; and storytelling and telling audiences “what you really think” moves people more than data dumps do. MAHA goes where audiences are listening, using podcasts, social media, and memes in ways most health institutions would scoff at—but it works. 3. They are very good at organizing. A MAHA meeting feels like a rally: energy, speakers, music, and most importantly, an action for everyone. Someone’s writing the next policy brief, someone’s seeding a narrative, someone knows the next legislative deadline, someone’s sending the text messages for a campaign. None of this is new (ask the civil rights movement), but MAHA knows it works and has capitalized on it. What MAHA gets wrong This list could be much longer, and this newsletter has spent a lot of time covering it, but here are a few things: Poor use of scientific evidence. This is the fundamental problem with many MAHA policies: the hype outpaces the science, and experts are often villainized for pointing this out. MAHA leadership has traded real solutions for cheap wins. For example, instead of taking on the powerful food industry and passing real reforms, it has celebrated french fries made of beef tallow and taken out artificial dyes from still very sugary children’s cereal. These changes won’t move the needle on America’s diet. MAHA leadership has tried to dismantle vaccine access in the U.S. While many MAHA supporters emphasize other issues, the effort to change vaccine policy has become MAHA’s signature effort. This is not surprising given RFK Jr.’s extensive track record campaigning against vaccines. It has rallied behind the wrong leader. RFK Jr. has a decades-long track record of villifying doctors, scientists, and public health workers, well before he became HHS secretary. He is known for his decades-long work sowing distrust in vaccines as well as life-saving treatments like antiretroviral therapy for HIV. This is not a serious person who can move the needle on health in the U.S, and he has already done serious damage. Public health needs more than defense Defending the evidence is absolutely necessary so health in the U.S. doesn’t move further backward. The public health establishment is very good at defense. The problem is this defense often sounds like defending the status quo, which has failed many people. Public health needs to offer an alternative to RFK Jr.’s MAHA—one that is rooted in evidence, truly listens to and addresses people’s frustrations, and has innovative solutions and the courage to change the systems. How do we get there? Find common ground. Do you know what most people care most about? The abysmal cost of healthcare. Start there. Fight for the human loudly. Too often, communications and engagement center on science with a capital S, funding mechanisms, or the CDC/FDA/NIH. Not the person. So the public doesn’t see themselves in it. Instead, they see people fighting for the very powerful systems that they feel negatively impact their health and well-being. Let the public feel and hear that you see their frustrations, you get it, and you’re fighting for them within the system. Recognize when pro-science messages are alienating people. Facts absolutely matter, but angrily venting only alienates people further. Our friend Elisabeth Marnik recently wrote a New York Times article about her experience growing up unvaccinated and how listening and empathetic conversation are the only ways to reach people that really work (a position backed by communication science). Her comments section was full of hateful comments from pro-vaccine individuals attacking her for daring to suggest we approach vaccine-hesitant individuals with empathy. It is possible to both stand firm behind scientific evidence and empathize with people who don’t trust it. Lean into politics smartly. Often, public health has shied away from politics: Don’t touch it, lest you get burned. But this fails to recognize that the third rail is what fuels the train: who is elected determines our budgets, our priorities, and our authority. Being political means being very savvy in strategy on both sides of the aisle, knowing your audience, and recognizing that political capital is as scarce as financial resources and needs to be allocated accordingly. Bottom line So does public health need MAHA? That’s not really the right question. Public health has a responsibility not to dismiss 40% of the country who feel heard by this movement and are frustrated that the system has failed them. And it has a responsibility to stick to the evidence and recognize MAHA leadership for what it is: a danger to our nation’s health. Both can, and should, be done. Love, YLE and KP A big thanks to Craig Spencer, who had the courage to put his neck out there to start a much-needed discussion at such a critical moment—one that is determining the identity of an entire field. Kristen Panthagani, MD, PhD is completing an emergency medicine residency and research fellowship focusing on health literacy and communication. In her free time, she writes the newsletters You Can Know Things debunking health myths and rumors and The Public Health Roundup. Views expressed belong to KP, not her employer. Your Local Epidemiologist (YLE) comprises a team of experts, ranging from physicians to immunologists to epidemiologists to nutritionists, working together with one goal: to “translate” ever-evolving public health science so that people are well-equipped to make evidence-based decisions. The YLE suite of newsletters reaches over 475,000 people across more than 132 countries. This newsletter is free to everyone, thanks to the generous support of fellow YLE community members. To support the effort, subscribe or upgrade below: Subscribe
Michigan Senate primary puts data center politics to the test
A statewide win for an outspoken data center critic could spread the message to more races.
FDA advisers support easing restrictions on six peptides. Here’s what those drugs are and what happens next
Peptides have become one of the hottest trends in wellness, with promises like faster muscle recovery and healthier aging. And six of these compounds cleared a major hurdle last week, when an advisory panel to the US Food and Drug Administration voted in favor of making them available through compounding pharmacies.
Cowboys, NFL Headlines: Position switch cancelled? Romo open container
The second day of training camp is in the books. Dak Prescott, Tyler Guyton, DaRon Bland and others gave their thoughts on their 2026 expectations.
Yankees news: Adley Rutschman and Jo Adell could be targets
Trade deadline targets and needs; Schlittler building Cy case; Judge wants team to be aggressive.
Maxi Araújo offered to Arsenal and Liverpool
Maxi Araujo’s representatives are sounding out Premier League interest, but Sporting remain determined to keep hold of one of their key players.Photo by Alex Pantling/Getty ImagesArsenal have again ...
FDA clears RadNet’s breast ultrasound AI solution
The product works by automating lesion detection, characterization and reporting, helping streamline workflows for both radiologists and sonographers.
College Sports Commission approves reworked NIL deals worth total of $7.5M for 18 Nebraska players
The College Sports Commission has approved $7.5 million in restructured name, image and likeness opportunities spread among 18 Nebraska football players after those deals initially were rejected in a decision upheld by an arbitrator two months ago.
In the unbridled online marketplace for peptides, one vendor is sentenced to nearly 6 years in prison
Rivian beats quarterly revenue estimates as R2 launch, software business gain traction
Rivian Automotive beat quarterly revenue estimates and raised annual delivery forecast on Thursday, buoyed by optimism over the rollout of its lower-priced R2 SUV and growth in its software business as it expands beyond its premium lineup.
The new "science golden age" looks suspiciously like a grift
This edition of PN is made possible by paid subscribers. Become one ⬇️ 🚀 Subscribe to PN 🚀 The Trump regime is trying to usher in a “Golden Age in Science” where scientific research is run like a Trump family business, artificial intelligence is all that matters, profit is everything, and expertise is for chumps. Or at least that’s the vision emerging from a new 123-page “Report to the President” from Michael Kratsios, the Director of the White House Office of Science and Technology Policy. In a normal administration, you could probably skip over learning about a science policy document — but this is no normal administration, and this is no normal science policy document. Instead, it’s Trump’s attempt to end the actual golden age of science that was kicked off in 1945 with the publication of '“The Endless Frontier” by Vannevar Bush. [ ](https://www.publicnotice.co/p/harmeet-dhillon-portland) [ Harmeet Dhillon demonstrates danger of posting through it ](https://www.publicnotice.co/p/harmeet-dhillon-portland) Liz Dye · Jul 29 [ Read full story ](https://www.publicnotice.co/p/harmeet-dhillon-portland) Bush, at President Franklin Delano Roosevelt’s request, laid out a vision of federal support for science that centered on funding universities to do basic research, saying that as long as those institutions were “vigorous and healthy and their scientists are free to pursue the truth wherever it may lead, there will be a flow of new scientific knowledge to those who can apply it to practical problems in Government, in industry, or elsewhere.” Kratsios’s report is supposed to be the successor to Bush’s, and even apes the format, but this isn’t really a document about science policy. It’s one about ending science research as we know it in favor of shoveling cash at big tech companies. While it might be temping to wave this away as an aspirational policy document, Trump has already begun to shift billions in research funds to AI projects and has taken a hatchet to science funding across the board. He’s teed up the shift Kratsios proposes here, and since neither Congress nor the Supreme Court seem inclined to stop him from doing whatever he wants with taxpayer money, it isn’t doomering or hyperbole to say we are staring down the barrel of a world where the only “science” the government intends to support is for-profit tech and defense advancements. Science for dummies Part of how you can tell this isn’t a document about science is that you are immediately faced with an absolute wall of business-speak of the worst sort. Did you know we must “tightly couple our science and technology enterprises to ensure that groundbreaking ideas invented in the United States are rapidly prototyped, tested, manufactured, and scaled domestically”? You do now! That tone isn’t surprising, because Kratsios has no background in science or research. He has a bachelor’s in political science and spent most of his career working for Peter Thiel at Thiel Capital. After a stint in the first Trump administration as Chief Technology Officer, where he also did not do any science, Kratsios was tasked in 2020 with overseeing the Pentagon’s research budget for a brief time, a position that, as the Wall Street Journal put it, “carries a great deal of power in terms of dictating investment allocations.” He spent the Biden years at Scale AI as “head of strategy,” which you will also note is neither a science nor a research job. But Scale AI has contracts with the Department of Defense and, as the Washington Post wrote in 2023, “has been aggressively pitching itself as the company that will help the US military in its existential battle with China.” And now you have the necessary background for our new golden age, which is going to be a golden age of taking money away from scientists and universities and giving it to companies like Scale AI. A note from Aaron: Working with brilliant contributors like Lisa takes resources. If you aren’t already a paid subscriber, please become one to support our work. 👇 Subscribe In a genuinely galling move, Katsios spends a lot of time slamming universities because of “administrative burdens on researchers” and the “well-documented inefficiencies” in academia, the message being that those damn universities waste the time of amazing researchers with paperwork. Except it’s the administration that is attempting to impose inefficient, unnecessary burdens on those researchers with a proposed Office of Management and Budget rule that would require senior political appointees to approve every science grant and ensure it aligns with Trump’s personal priorities. Researchers would also have to seek prior government approval to attend conferences or publicize their research. And political appointees could terminate any grant at any time if they feel like it. [ ](https://www.publicnotice.co/p/omb-rule-science-funding) [ The murder of expertise ](https://www.publicnotice.co/p/omb-rule-science-funding) Lisa Needham · Jun 11 [ Read full story ](https://www.publicnotice.co/p/omb-rule-science-funding) But when it comes to AI, we’re going to “restore permissionless innovation.” The report proposes to give lucky ducky innovators a pile of cash up front for grants lasting five years or longer, saying “awards should be fully-funded in year one, with all resources earmarked upfront, to minimize administrative burdens and reduce pressure for researchers to generate intermediate results to secure continued funding.” Yeah, wouldn’t want to have to make the Very Special Tech Bros show results or get money parceled out year by year like the plebes at universities. The report also proposes that we should have “fast grants” with “simplified applications requiring just a few pages of writing” because that is definitely how science works, just writing a bit off the dome and getting some cash. [ ](https://www.publicnotice.co/p/trump-ai-action-plan-altman-llms) [ Tech elites are turning AI into ChatGPTrump ](https://www.publicnotice.co/p/trump-ai-action-plan-altman-llms) Paul Waldman · July 29, 2025 [ Read full story ](https://www.publicnotice.co/p/trump-ai-action-plan-altman-llms) Oh, and we should have prizes and challenges, where multiple teams compete. The proposed prizes include incentives like “advance procurement commitments,” which means the federal government agrees to buy whatever is being developed. There’s also “regulatory fast-tracking,” making sure all those great AI thingies don’t have to wait too long to be unleashed on a market. These aren’t incentives to do science. These are incentives to develop things with tax dollars that you can then sell to the government for more tax dollars. In the suggestion that might be the most unhinged, the most very opposite of how both government and research work, our new age will include “golden tickets.” That’s where an individual reviewer in an agency — yes, just one person — can “recommend unconventional proposals that may not pass consensus-driven review panels” because somehow this will “surface valuable ideas too divisive for committees and attract higher quality reviewers by empowering them to exercise independent scientific judgment.” Yes, that’s saying that a random person in an agency should be able to shovel money at some idea even if it can’t pass a review panel, and that the opportunity to do so will attract better employees because apparently all the best minds in science are chomping at the bit to be allowed to unilaterally fund AI research based on their personal vibes. But that isn’t at all how actual science works, and actual scientists aren’t unhappy about review panels. They work collaboratively, not siloed in some secret race to create the next AI chatbot. A 2020 study by the National Bureau of Economic Research examined whether peer review panels succeed in helping agencies predict which research ideas will best advance science. Peer review was better at finding “diamond in the rough” applicants than a single government program official. How about that. Trump always wants a taste It’s painfully clear that what Katsios is trying to do here is turn the whole of government science research and funding into the sort of “move fast and break things” paradigm that is the hallmark of big tech. That method works to line the pockets of tech executives, but it isn’t science. There’s a reason the government funds different kinds of research than private tech companies do. What Katsios either fails to understand or deliberately ignores is that the federal government is the main funder of basic research precisely because it can take a long time for it to bear fruit and is not intended to be profitable as such. “Basic” here does not mean rudimentary or simple, but rather research that is designed to advance scientific knowledge instead of achieving a specific outcome or product. Big tech companies don’t widely fund that sort of research, because it doesn’t make them money. Industry dollars account for only about 20 percent of basic research funding, while the government contributes around 60 percent. Big tech companies and startups do, however, rely on and benefit from that basic research. A 2019 study found that 35 percent of all patents obtained by venture-backed startups from 1976 to 2016 cited federally supported research. Basic research funded by the NIH contributed to every single drug the FDA approved from 2010 to 2016. [ ](https://www.publicnotice.co/p/trump-saudi-nuclear-deal) [ The Saudi nuclear farce and governance by whim and meme ](https://www.publicnotice.co/p/trump-saudi-nuclear-deal) Noah Berlatsky · Jul 27 [ Read full story ](https://www.publicnotice.co/p/trump-saudi-nuclear-deal) Unlike inventing the next ChatGPT, actual science is slow and iterative. Government funding of research that, on its face, would not appear to lead to any big new invention is actually what underpins those big new inventions. If the government hadn’t funded research into desert lizard venom, we wouldn’t know about semaglutide, and we wouldn’t have Ozempic. If research scientists hadn’t studied how bees optimize nectar foraging within a colony, we wouldn’t have the algorithm that assigns internet traffic across computer servers. The report assiduously ignores that a symbiotic, profitable relationship between the federal government, universities, and private companies already exists. Each federal research dollar generates about $1.50 to $3.00 in long-term economic benefits. The $36 billion the government awarded in NIH research funding in fiscal year 2025 generated $94 billion in new economic activity. Trump’s proposed new golden age is intended to strip those billions from universities, resulting in the dismantling of departments and the shuttering of labs. But Katsios has a plan for that: Universities should just become trade schools to churn out no-show STEM degrees! “Require universities and community colleges to embed practical technical training and externships into STEM curricula. Let hands-on experience and industry credentials count toward degrees.” It’s quite the feat to, on the one hand, strip schools of funding for scientific research while simultaneously demanding to control what is taught and, oh, also, colleges need to give degrees to employees at big tech companies just for being employees at big tech companies. The new golden age would also exacerbate the brain drain Trump’s policies have already caused. Nature found that in the first quarter of 2025, US scientists submitted 32 percent more job applications abroad than in 2024. A March 2025 poll by Nature of roughly 1,600 scientists found that over 1,200 said they were considering leaving the country. Europe is investing $565 million to make it a “magnet for researchers” and provide funding for scientists who relocate. The new golden age is also about embedding Trump’s xenophobia into the fabric of American science. The report complains of an “over-reliance on foreign students” that “creates a security challenge our institutions are ill-equipped to address” and that a “reliance on foreign talent sidelines American students.” This is, to put it mildly, nonsense. International students pay far higher tuition and often receive no financial aid. Their tuition dollars are what make it possible for American students to get financial aid. In the 2023-2024 school year alone, international students contributed $43.8 billion to the US economy and supported over 378,000 jobs. Those 1.1 million international students accounted for only six percent of the total number of students in higher education that year, but were such an economic engine that for every three international students, one job was created or supported. It’s impossible not to wonder whether part of Trump’s loathing for universities and their leading role in scientific research is that there is no way for him to corrupt the process and make money off it in the same way he can by giving millions and billions to Silicon Valley types who, in turn, give him millions in cash. There’s no way for his children to invest in universities that the government then gives no-bid contracts to, fattening the family’s bottom line, which is pretty much the Trump sons’ current venture capital practice. Trump and Katsios’s view of science is narrow, cramped, and wrong. We’re not in a crisis, we’re not a failed state. We’ve been a science superpower for decades, and the only thing that threatens that is Donald Trump. Tech bros are already living high off the hog in this administration. They don’t need any more of our tax dollars. Hopefully this new golden age never comes to pass. Thanks for reading Public Notice. This post is public so feel free to share it. Share We’ll be back with more tomorrow. If you appreciate today’s PN, please do your part to keep us free by signing up for a paid subscription. 🚀 Subscribe to PN 🚀 Thanks for reading, and for your support.
KFF Health Tracking Poll: Mifepristone and the Midterms
Amid an ongoing FDA re-review of mifepristone, awareness of the safety and prevalence of the abortion pill remains limited. This KFF poll also finds that the voters who say abortion policy is an important issue for 2026 midterm candidates to discuss are disproportionately Democrats.
Reds CEO Hogan on potential investor Bhatia
With Liverpool stating that they have more than 26 million supporters in the USA, there is little surprise over why the Reds chose America as the destination for their pre-season tour. This has been quite the summer for football here and Billy Hogan, CEO of Liverpool and Fenway Sports Group (FSG), insists the aim is to build on that after what has been a "super difficult year" for the club "for lots of different reasons". Last week, FSG, which owns Liverpool, confirmed that a consortium led by Amit Bhatia, a British-Indian millionaire businessman, was in talks over a strategic minority investment in the club.
Miami Called out Unexpectedly by $5 Million Superstar
This wealthy star caught the attention of Miami with his words. The post Miami Called out Unexpectedly by $5 Million Superstar appeared first on HEAVY.
Mario Vargas Llosa by Gerald Martin review – the passions and politics of Peru’s Nobel laureate
This stylish biography of the author traces his journey from left to right, and from ‘posh Lima’ to Cricklewood
Mobile business owner says he shot and killed man in self defense
Mobile police responded to a deadly shooting at Chips Auto Glass on Halls Mill Road on July 28. Investigators say 25-year-old Evan Bagley came to the business, got into an argument with another man, and pointed a gun at him.
Duchess Meghan reveals Prince Harry's sweet advice for 'hard days'
If Prince Harry has taught Duchess Meghan anything over the years, it's how to look on the bright side.
Oldest Congress ever faces fresh scrutiny over their health
Pressure is building on Sen. Mitch McConnell after more than six weeks away from the Senate with little public information about his condition.
Oldest Congress ever faces fresh scrutiny over their health
Pressure is building on Sen. Mitch McConnell after more than six weeks away from the Senate with little public information about his condition.
Hegseth offers soldiers testosterone and FDA loosens safety warnings. Is the science there?
Last week, the Pentagon posted a video on X announcing they will be mandating testosterone screening for troops in the military aged 30 and above. If they test low, they will be offered voluntary testosterone replacement therapy. This episode is available on Apple Podcasts, Spotify, and Youtube. At the same time, FDA has announced it […]
FDA authorizes first AI tech for visualizing coronary inflammation in CT scans
Cardiac imaging experts have been anticipating this news for quite some time. The belief is that it could help transform how clinicians evaluate cardiovascular risk.
Madison Comedy Week features 90 comedians at nine venues
Now in its eighth year, Madison Comedy Week offers locals a chance to see talented up-and-coming comedians across the city.
Michael Malone Keeps Important UNC Basketball Team-Bonding Tradition Alive With Outer Banks Trip
Michael Malone continued UNC basketball’s annual Outer Banks trip, giving a rebuilt Tar Heel roster a valuable opportunity to develop chemistry away from campus before the 2026-27 season.
Madeira business owners say years-long construction project is threatening their survival
Shops report 30% drop in revenue as redevelopment project stretches into third year
Kavinsky, French DJ known for 'Drive' opening song, dies at 50
Kavinsky, the French DJ and electropop musician who performed at the Paris Olympics and gave the Ryan Gosling movie "Drive" its memorable opening credits track, has died. He was 50.
Elderly resident struggling with displacement, health issues after air conditioning failure at Broward condo
Yankees Add Veteran Catcher Ahead of Trade Deadline
The New York Yankees have signed a veteran catcher to a minor league deal ahead of the MLB trade deadline.
10 takeaways from Day 4 of Patriots training camp
After a slower walkthrough practice on Monday, the Patriots ramped up the pace on Day 4 of training camp.
FDA clears AI software for limiting false-positive ICM alerts
The cloud-based software from Implicity was built to help care teams reduce unnecessary alerts and prioritize patients who truly need care.
Abbott gathering real-world data on FDA-approved TriClip system
Abbott's TriClip system for tricuspid regurgitation is approved by the FDA and covered by Medicare. To learn more about its real-world performance, researchers will now track 1,000 patients for a total of five years.
Notre Dame football running back preview for the 2026 season
Notre Dame RB Kedren Young is nearly a full year removed from his ACL tear, which makes him a candidate for short-yardage and goal-line assignments.
New England Patriots 2026 schedule and scores
Complete New England Patriots schedule and results for the 2026-27 season. All times are Eastern Time.
Trinity Health Livingston launches new community leadership council
The Guardian view on Europe’s wildfires: politics must catch up with the new reality
Editorial: At a time when the quickening pace of global heating has never been clearer, climate policies are being deprioritised
FDA shares warning about stroke prevention device after injury
Customers should return these devices to the manufacturer, Boston Scientific, due to a risk of the tip separatng during use.
Cowboys Headlines: What's the mindset as 2026 training camp commences?
After the moves made on defense, it's time for the Cowboys offense to take on a more aggressive mindset. This and more from around the NFL.
Healthcare Triangle Creates "Purpose Health" to Monetize AI Demand and Accelerate Shareholder Returns
Healthcare Triangle, Inc. (NASDAQ: HCTI), a healthcare and life sciences technology company enabling digital transformation through cloud, data, artificial intelligence, and security solutions, today announced that proven industry executive Sumit Ganguli has been appointed Chairman and Chief Executive Officer of Purpose Health, Inc., HCTI's wholly owned, AI-led healthcare technology services subsidiary.
Biggest Winners and Losers From Bucks’ 2026 Offseason
Who came out of the Milwaukee offseason looking good?
FDA takes up peptide therapies as hype outpaces science
A slate of popular peptide therapies has won the backing of a key advisory panel to the federal government – a step that could eventually open up broader
FDA rejects application for new oral MR imaging contrast agent
Biotechnology firm Ascelia Pharma is working to roll out Orviglance, a novel manganese-based product for visualizing focal liver lesions during MRI, but faced a recent setback.
ESPN super computer predicts every Texas Longhorns game in 2026
The Longhorns have one of the toughest schedules in the nation. But the ESPN FPI computers are very bullish on Texas.
Cyclospora outbreak has many changing eating habits, CBS News poll finds; mixed and partisan confidence in FDA
Once valued at $2B, this Utah tech darling is selling off its business for a fraction of that
After racking up nearly a billion dollars in losses, a company once seen as a premier Utah tech success story is selling its core business.
Mike Vrabel’s second act will define his Patriots legacy
Reaching the Super Bowl once proves you're a good coach. Sustaining excellence—proves you're great. Which one is Vrabel?
Once an adventurer, Dr. Anne Zink offers health and safety tips for travelers
While the crisis of COVID-19 is mostly behind us, new health-related issues are causing travelers to pay attention to how and where they travel.
Brazil uses forensic science to trace gold’s origin and tackle illegal mining in the Amazon
The work takes place at the National Institute of Criminalistics in Brasilia, the country’s capital, where federal police have set up a “gold lab” that collects and analyses samples from across the country.
Poll: Are the Red Sox for Real?
The Boston Red Sox begin a three-game series at home against the Toronto Blue Jays Friday night, looking to start a new winning streak. The Red Sox lost the nightcap of a Wednesday doubleheader against the Baltimore Orioles — ending the team’s remarkable 15-game winning streak, which had tied a team record last accomplished in 1946. When the streak began, Boston was considered an also-ran in the AL playoff race.
The White House’s MAHA Gatekeeper
A policy wonk who could lead the FDA has angered “Make America Healthy Again” activists.
TxDOT announces Business 6 Flyover closure in Navasota
he Texas Department of Transportation (TxDOT) announced the planned closure of the Northbound Business 6 flyover starting on July 24
FDA panel votes to loosen restrictions for controversial peptides
The vote marks a win for Health Secretary Robert F Kennedy who has said he's a big fan of the drugs, which haven't been well studied for human use.
Mark Cuban, Rashaun Williams Firm Buys Stake in Vegas A’s
It’s the first investment by Harbinger Sports Partners, which formed last May.
FDA says it identified new cyclospora outbreak linked to unspecified product
Eagles Get More Bulletin-Board Material Ahead of 2026 Season
The Philadelphia Eagles are the two-time reigning NFC East champs, and are just 18 months removed from the Super Bowl. The Eagles were 11-6 in 2025, a three-game drop off from the 2024 season where they won 14 games and defeated the Kansas City Chiefs 40-22 in Super Bowl LIX. Plus, Philadelphia fell 23-19 to the San Francisco 49ers in the wild-card round.
FDA reviews peptide injections favored by RFK Jr. and wellness influencers
Federal health advisers are meeting to review a group of controversial chemicals called peptides
US regulators to weigh controversial peptides backed by RFK Jr
FDA has questioned the evidence as demand surges for the compounds promoted for sleep, muscle growth, and anti-aging.
FDA sees early promise in new gene therapy for BAG3-associated DCM
An investigational drug therapy from Affinia Therapeutics has secured the FDA's orphan drug designation. This means the company now has access to certain benefits, including tax credits and fee exemptions, as it works toward approval.
Biotech experts want FDA drug reviews based on science, not politics
Biotech experts call for the FDA to prioritize scientific expertise over political influence in drug reviews amid recent leadership changes and staffing challenges.
Quorum Health, a private equity-backed hospital chain, is going nonprofit
After years of trying different strategies, one private equity backed company has decided its best, and maybe only, option is to turn its 11 hospitals back into nonprofits.
Biotech experts want FDA drug reviews based on science, not politics
Biotech experts and industry executives are calling plans by the U.S. Food and Drug Administration — hit by job cuts last year — to hire thousands of employees and update clinical-trial standards encouraging, but want assurance that politics will not interfere in the agency's drug-review process.
Biotech experts want FDA drug reviews based on science, not politics
Biotech experts and industry executives are calling plans by the U.S. Food and Drug Administration — hit by job cuts last year — to hire thousands of employees and update clinical-trial standards encouraging, but want assurance that politics will not interfere in the agency's drug-review process.
Biotech experts want FDA drug reviews based on science, not politics
July 22 (Reuters) - Biotech experts and industry executives are calling plans by the U. Food and Drug Administration — hit by job cuts last year — to hire thousands of employees and update clinical-trial standards encouraging, but want assurance that politics will not interfere in the agency's drug-review process.
Does the science of peptides live up to the hype?
Synthetic peptides are getting some serious hype, from fitness influencers on your FYP to people seeking new options for chronic conditions. And while the human body already makes peptides, like insulin and the hormone oxytocin, most of the viral synthetic peptides are not approved by the Food and Drug Administration. Scientists say that raises some big concerns about safety and efficacy. So ahead of this week’s FDA meeting to discuss seven commonly used peptides, we get into the science with health reporter Sarah Boden.Interested in more science behind health trends? Email us your question at shortwave@npr.org.Support public media with NPR+ and enjoy perks for over 25 podcasts like this one. It includes perks like bonus episodes, early access, archive access, curated playlists and sponsor-free listening. Learn more at plus.npr.org.
Looking at Portland's business climate with Columbia Sportswear CEO Tim Boyle
As Columbia Sportswear celebrates a major win in the world of advertising, the company's CEO says Portland's economic challenges might be too much to bear.
Health: Searching For The Source Of Cyclospora
You may have heard of a parasite that’s causing some gastrointestinal distress.Cyclospora has sickened thousands of people across 34 states this summer – more than six times the number reported at this point last year. The CDC has linked a major cluster to shredded iceberg lettuce at Taco Bell in some states. And Taylor Farms de Mexico has now pulled all of its iceberg lettuce from the U.S. market despite an FDA finding that reports that its product contained the parasite were a false positive.We answer your questions about what cyclosporiasis is, how you get it, and why investigators have had such a hard time finding the source.Find more of our programs online. Listen to 1A sponsor-free by signing up for 1A+ at plus.npr.org/the1a.
New Skipper Science App program to fill data gaps in Bristol Bay sport fishery
In all Alaskan fisheries, good data is a critical part of management. But the collection of that data doesn't have to be left to just scientists. Within Bristol Bay's sport fishery, there's a new way for guides to report their catches and observations, helping build a robust record of Bristol Bay catches.
DiMe launches initiative to build operational AI governance tools
With the support and expertise of Qualified Health, FDA and 30 healthcare organizations and tech companies, the Digital Medicine Society says it will release tools that enable broader adoption of artificial intelligence as they are created.
Cowboys players with the highest floor for this season
Which players on the Cowboys do you think have the highest floors?
Cyclospora False Positive? Why We Should Still Trust Outbreak Science
Cyclospora lab test retraction by FDA does not negate outbreak science.
FDA’s Review Of Peptides Signals A Growing Public Health Challenge— Separating Science From Hype
A FDA advisory committee will review evidence surrounding peptides. Experts are concerned there is a paucity of evidence to back their approval for legal compounding.
Lilly’s $2.8 Billion Bet on Psychedelics Buys Science That Conventional Trial Infrastructure May Not Be Able to Run
Eli Lilly acquires AtaiBeckley for $2.8B, but the FDA's final psychedelic trial guidance reveals an operational crisis Big Pharma hasn't priced in.
Holland & Knight Health Dose: July 21, 2026 | Insights
U.S. Congress races toward the August 2026 recess as lawmakers advance healthcare, FDA and CMS priorities, appropriations, transparency measures and reimbursement policy.
Democrats drive voter opposition to data centers, POLITICO Poll finds
A new POLITICO Poll found that Americans’ attitudes toward data centers have grown increasingly sour and politically polarized in the past six months.
49ers News: It’s “best shape of their lives” season
Your daily San Francisco 49ers news for Tuesday, July 21st, 2026
FDA issues recall of portable imaging systems
A notice from the agency indicates that systems that have had column replacements might not function appropriately afterward and could pose patient harm.
J.J. McCarthy Receives Strong Take Amid Vikings QB Competition
The Minnesota Vikings will use a QB competition between J.J. McCarthy and Kyler Murray to determine their starter for the 2026 NFL season. Nonetheless, even with the competition ongoing, many expect Murray to emerge victorious.Murray is looking to show that he’s still a starting QB despite the Arizona Cardinals cutting ties with him this offseason. […] The post J.J. McCarthy Receives Strong Take Amid Vikings QB Competition appeared first on HEAVY.
Atlanta Braves Make Correct Decision With Ronald Acuna Jr.
The Braves have a plan, and it's the right one.
Federal health officials have investigated 5 different clusters of cyclosporiasis cases, FDA says
Federal health officials have been investigating five different clusters of cyclosporiasis cases since the start of parasite season in May, the FDA said on Monday.
Federal health officials have investigated 5 different clusters of cyclosporiasis cases, FDA says
Federal health officials have been investigating five different clusters of cyclosporiasis cases since the start of parasite season in May, the FDA said on Monday.
Can 'One Man' Carry Seahawks' Super Bowl Repeat Hopes?
Last season, it was the Jaxon Smith-Njigba show on offense, but can he do it again?
FDA is still focused on lettuce supplier as source of parasite, despite faulty test result
Federal health officials said Monday they remain focused on lettuce from Taylor Farms as the source of a multistate outbreak of a diarrhea-causing parasite, despite inaccurate test results that the government briefly publicized over the weekend.
Federal health officials have investigated 5 different clusters of cyclosporiasis cases, FDA says
Federal health officials have been investigating five different clusters of cyclosporiasis cases since the start of parasite season in May, the FDA said on Monday.
FDA says it’s still investigating Taylor Farms in cyclosporiasis outbreak
A false-positive test result doesn’t change the “overwhelming epidemiological data” linking Taylor Farms to the outbreak, the FDA said.
FDA’s Home as a Health Care Hub Initiative and the READI-Home Innovation Challenge: Key Takeaways for Device Sponsors
Key Takeaways The U.S. Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health (CDRH) opened its READI-Home Innovation Challenge, offering up to nine device sponsors early,…
FDA retracts test result but still links Taylor Farms lettuce to cyclosporiasis
The FDA did not back away from its conclusion that the company remains linked to a multistate outbreak of cyclosporiasis through its investigation.
Paramount/Warner Bros. merger will make media more MAGA
Larry and David Ellison's political ambitions will suck the joy out of TV and movies
Should Commanders target Patriots wide receiver before Week 1?
If the Commanders look to make a move, another former Jayden Daniels' teammate could make some sense.
Traverse City business incubator names a startup veteran to top role
Stacey Feeley will helm the business incubator 20Fathoms after years as an entrepreneur herself.
Seven peptides are under review by an FDA panel this week. Here’s everything we know
The committee will discuss whether compounding pharmacies can make the peptides in question. But FDA scientists say there’s little — if any — evidence they work in humans.
‘Shrimad Bhagavatam’ Anchors Sagar Pictures Entertainment’s Global Push, Indian Studio Confirms (EXCLUSIVE)
Sagar Pictures Entertainment (SPE) has confirmed the launch of a global studio business, moving beyond film and television production into an intellectual property-led growth strategy spanning gaming,...